- EN
Table TDI-17. Route of administration by primary drug of clients entering treatment, 2011 or most recent year available
Part (ix) New cannabis outpatient clients by country and usual route of administration (%)
| Country | Inject | Smoke/inhale | Eat/drink | Sniff | Others | Route known (n) | Route unknown | |
|---|---|---|---|---|---|---|---|---|
| Belgium | 0.1 | 98.8 | 0.8 | 0.2 | 0.1 | 926 | 14 | |
| Bulgaria | 0.0 | 100.0 | 0.0 | 0.0 | 0.0 | 7 | 0 | |
| Czech Republic | 0.0 | 99.7 | 0.0 | 0.3 | 0.0 | 324 | 0 | |
| Denmark | 0.0 | 98.2 | 1.8 | 0.0 | 0.0 | 942 | 89 | |
| Germany | 0.2 | 98.4 | 1.1 | 0.2 | 0.2 | 12263 | : | |
| Estonia | : | 100.0 | : | : | : | 19 | : | |
| Ireland | 1 | 0.0 | 99.2 | 0.8 | 0.0 | 0.0 | 846 | 1 |
| Greece | 0.0 | 99.8 | 0.2 | 0.0 | 0.0 | 456 | 5 | |
| Spain | 1 | 0.0 | 97.0 | 2.1 | 0.5 | 0.4 | 8504 | 149 |
| France | : | 99.4 | 0.5 | : | 0.0 | 6490 | 349 | |
| Italy | 2 | 0.0 | 96.4 | 0.6 | 2.8 | 0.2 | 5316 | 465 |
| Cyprus | 0.0 | 99.7 | 0.3 | 0.0 | 0.0 | 310 | 1 | |
| Latvia | 3 | 1.4 | 98.6 | 0.0 | 0.0 | 0.0 | 69 | 4 |
| Lithuania | : | 44.4 | 55.6 | : | : | 9 | : | |
| Luxembourg | : | : | : | : | : | : | : | |
| Hungary | 0.1 | 94.8 | 4.1 | 0.8 | 0.2 | 2073 | 15 | |
| Malta | : | 97.4 | 2.6 | : | : | 38 | : | |
| Netherlands | 0.0 | 99.6 | 0.2 | 0.1 | 0.0 | 2840 | 1194 | |
| Austria | 0.0 | 97.4 | 1.9 | 0.6 | 0.2 | 534 | 13 | |
| Poland | 4 | : | 98.8 | : | 1.2 | : | 81 | : |
| Portugal | 5 | 0.0 | 98.5 | 1.5 | 0.0 | 0.0 | 329 | 128 |
| Romania | 0.0 | 96.7 | 3.3 | 0.0 | 0.0 | 60 | 0 | |
| Slovenia | : | 100.0 | : | : | : | 39 | : | |
| Slovakia | 1.9 | 93.4 | 0.9 | 3.8 | 0.0 | 106 | 0 | |
| Finland | 0.0 | 98.6 | 1.4 | 0.0 | 0.0 | 69 | 0 | |
| Sweden | 1 | 0.0 | 96.3 | 3.3 | 0.3 | 0.0 | 575 | 10 |
| United Kingdom | 6 | 0.0 | 95.9 | 2.9 | 0.6 | 0.5 | 14067 | 374 |
| Croatia | 0.0 | 100.0 | 0.0 | 0.0 | : | 576 | 0 | |
| Turkey | : | : | : | : | : | : | : | |
| Norway | : | : | : | : | : | : | : | |
| Total | 0.1 | 97.5 | 1.6 | 0.6 | 0.3 | 57868 | 2811 |
Notes:
: Indicates no data are available.
Percentages are of clients whose route of administration is known (n)
1 - Data are from 2010.
2 - In 2010 around 27% of all clients and 32% of new clients were registered as not known / missing for the primary drug category. Caution should be made when comparing data over time.
3 - In 2010 Latvia submitted a new dataset with a more precise TDI EMCDDA definition. Caution should be made when comparing data with previous years.
4 - Data are from 2010. Data presented in the table come from TDI pilot project. Caution should be made when interpreting the data.
5 - In 2010 came into implementation a new national information system implying methodological changes particularly in the registration criteria. Caution should be made when comparing 2010 data with previous years.
6 - Data are from 1st of April 2010 to 31st March 2011.
For more information relative to the treatment centre type, please see Table TDI-7.
See also 'General notes for interpreting data' on the Explanatory notes and help page.
Source:
Reitox national reports 2012 — TDI — outpatient treatment centres.